Back to search results

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Abroad (travel likely)RecruitingPHASE3

Conditions

Epithelial Ovarian Cancer · Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Advent Health, Orlando, Florida, United States

    Contact: Study coordinator (Karla Hernandez-Cruz) · Karla.Hernandez-Cruz@AdventHealth.com
    Contact: Principal Investigator (Robert Holloway, MD)

  • Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Safiya Easthausen) · easth017@umn.edu
    Contact: Principal Investigator (Melissa Geller, M.D.)

  • Washington University School of Medicine in St. Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Missy Bradlo) · bradlom@wustl.edu
    Contact: Principal Investigator (Andrea Hagemann, MD)

  • Providence Cancer Institute, Portland, Oregon, United States

    Contact: Study coordinator (Nora Auston) · Nora.Auston@providence.org
    Contact: Principal Investigator (Christopher Darus, MD)

  • Sanford Health, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Ashley Johnson) · ashley.johnson9@sanfordhealth.org
    Contact: Principal Investigator (Maria Bell, MD)

  • Erlanger Health, Chattanooga, Tennessee, United States

    Contact: Study coordinator (Kimberly Donelson) · kimberly.donelson@erlanger.org
    Contact: Study coordinator (Lorraine Christensen) · lorraine.christensen@erlanger.org
    Contact: Principal Investigator (Stephen DePasquale, MD)

  • Providence Sacred Heart Medical Center & Children's Hospital, Spokane, Washington, United States

    Contact: Study coordinator (Jodie Mactagone) · jodie.mactagone@providence.org
    Contact: Principal Investigator (Melanie Bergman, MD)

  • Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Maia Terashvili) · mterashv@mcw.edu
    Contact: Principal Investigator (William Bradley, MD)
Study leads

  • Premal H Thaker, M.D.

    Study Chair

    Washington University School of Medicine

View source on ClinicalTrials.gov(opens in a new tab)